Laura Beretta
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
-
- Metabolomics and Mass Spectrometry Studies 12
- Epidemiology 27
- Liver Disease Diagnosis and Treatment 22
- Hepatitis B Virus Studies 7
- Co-authors
- Samir Hanash (14 shared papers)Nahum Sonenberg (6 shared papers)Jorge A. Marrero (5 shared papers)George N. Ioannou (3 shared papers)Yuri V. Svitkin (2 shared papers)Anne‐Claude Gingras (2 shared papers)Michael N. Hall (1 shared paper)Silvia Cermelli (2 shared papers)
- Journals
- Journal of Biological Chemistry (8 papers)Hepatology (7 papers)PROTEOMICS (6 papers)Cancer Prevention Research (5 papers)Molecular & Cellular Proteomics (5 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Laura Beretta
106 papers receiving 5.7k citations
Laura Beretta's Hit Papers
Peers
Comparison fields: 5 of 120
- Hepatology 912
- Cancer Research 900
- Cell Biology 719
- Molecular Biology 2.9k
- Immunology 856
Countries citing papers authored by Laura Beretta
This map shows the geographic impact of Laura Beretta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Beretta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Beretta more than expected).
Fields of papers citing papers by Laura Beretta
This network shows the impact of papers produced by Laura Beretta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Beretta. The network helps show where Laura Beretta may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Beretta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation. Hit paper breakdown → | 1996 | 584 |
| 2 | 2011 | 473 | |
| 3 | 2011 | 270 | |
| 4 | 2001 | 244 | |
| 5 | 2007 | 240 | |
| 6 | 2004 | 188 | |
| 7 | 2002 | 166 | |
| 8 | 1989 | 152 | |
| 9 | 1993 | 152 | |
| 10 | 2005 | 144 | |
| 11 | 2013 | 137 | |
| 12 | 2007 | 132 | |
| 13 | 2002 | 129 | |
| 14 | 2017 | 99 | |
| 15 | 1989 | 90 | |
| 16 | 2015 | 87 | |
| 17 | 2015 | 80 | |
| 18 | 2006 | 80 | |
| 19 | 2011 | 78 | |
| 20 | 2001 | 73 |
About Laura Beretta
Laura Beretta is a scholar working on Molecular Biology, Epidemiology, Hepatology, Cell Biology and Immunology, having authored 109 papers that have together received 5.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Advanced Proteomics Techniques and Applications (13 papers), Metabolomics and Mass Spectrometry Studies (12 papers), Hepatitis C virus research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Hepatitis B Virus Studies (7 papers) and interferon and immune responses (7 papers). The work is most often cited by research in Hepatology (912 citations), Cancer Research (900 citations), Cell Biology (719 citations), Molecular Biology (2.9k citations) and Immunology (856 citations). Laura Beretta has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Samir Hanash, Nahum Sonenberg, Jorge A. Marrero, George N. Ioannou, Yuri V. Svitkin, Anne‐Claude Gingras, Michael N. Hall, Silvia Cermelli, A Sobel and Anna Ruggieri. Their work appears in journals such as Journal of Biological Chemistry, Hepatology, PROTEOMICS, Cancer Prevention Research and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.